Φορτώνει......
A Sativex®-like combination of phytocannabinoids as a disease-modifying therapy in a viral model of multiple sclerosis
BACKGROUND AND PURPOSE: Sativex® is an oromucosal spray, containing equivalent amounts of Δ(9)-tetrahydrocannabinol (Δ(9)-THC) and cannabidiol (CBD)-botanical drug substance (BDS), which has been approved for the treatment of spasticity and pain associated to multiple sclerosis (MS). In this study,...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Br J Pharmacol |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
John Wiley & Sons, Ltd
2015
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4507161/ https://ncbi.nlm.nih.gov/pubmed/25857324 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.13159 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|